Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients

Annals of Hematology

Volumn 89, Issue 5, 2010, Pages 523-525

  Kalin, Mats ^a   Kristinsson, Sigurdur Yngvi ^a   Cherif, Honar ^a   Lebbad, Marianne ^b   Björkholm, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; C REACTIVE PROTEIN; COTRIMOXAZOLE; DACARBAZINE; DOXORUBICIN; VINBLASTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ASSISTED VENTILATION; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MYELOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PNEUMOCYSTIS JIROVECI; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; VINBLASTINE; YOUNG ADULT;

EID: 77950571344     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0833-4     Document Type: Letter

References (10)

1. G Bollee C Sarfati G Thiery, et al. 2007 Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients Chest 132 1305 1310 10.1378/chest.07-0223 17934116 (Pubitemid 47621008)
2. L Pagano L Fianchi L Mele, et al. 2002 Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years experience of infection in GIMEMA centres Br J Haematol 117 379 386 10.1046/j.1365-2141.2002. 03419.x 11972521 (Pubitemid 34451154)
3. F Roblot G Le Moal C Godet, et al. 2003 Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study J Infect 47 19 27 10.1016/S0163-4453(03)00038-0 1:STN:280:DC%2BD3szitV2iuw%3D%3D 12850158 (Pubitemid 36850131)
4. CF Thomas Jr AH Limper 2004 Pneumocystis pneumonia N Engl J Med 350 2487 2498 10.1056/NEJMra032588 1:CAS:528:DC%2BD2cXkvVGnsr0%3D 15190141 (Pubitemid 38736546)
5. WT Hughes S Kuhn S Chaudhary, et al. 1977 Successful chemoprophylaxis for Pneumocystis carinii pneumonitis N Engl J Med 297 1419 1426 1:STN:280:DyaE1c%2FltFSjsg%3D%3D 412099
6. UM Overgaard J Helweg-Larsen 2007 Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004 Scand J Infect Dis 39 589 595 10.1080/00365540601150497 17577823 (Pubitemid 47009170)
7. KM Elvin A Bjorkman E Linder, et al. 1988 Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies Bmj 297 381 384 10.1136/bmj.297.6645.381 1:STN:280: DyaL1czhtValtw%3D%3D 3044514
8. G Bonadonna R Zucali S Monfardini, et al. 1975 Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP Cancer 36 252 259 10.1002/1097-0142(197507)36:1<252:: AID-CNCR2820360128>3.0.CO;2-7 1:STN:280:DyaE28%2FptVWnug%3D%3D 54209
9. O Tullgren G Grimfors G Holm, et al. 1991 Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up Cancer 68 768 775 10.1002/1097-0142(19910815)68:4<768::AID-CNCR2820680418>3.0. CO;2-1 1:STN:280:DyaK3MzgvFSiuw%3D%3D 1855177
10. J Fillaux S Malvy M Alvarez, et al. 2008 Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia J Microbiol Methods 75 258 261 10.1016/j.mimet.2008.06.009 1:CAS:528:DC%2BD1cXhtV2jtr7O 18606198